https://www.techtarget.com/pharmalifesciences/news/366606876/AstraZeneca-Alexion-Neurimmune-to-Develop-Rare-Disease-Antibody
AstraZeneca, Alexion, Neurimmune to Develop Rare Disease Antibody | TechTarget
AstraZeneca Rare Disease and Alexion group recently closed a global collaboration and license agreement with Neurimmune AG for the investigational human...
to developrare diseaseastrazenecaalexionneurimmune